Clinical Trial Update: Study of STA-1 as an Add-on Treatment to Donepezil [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating STA-1 as an add-on to donepezil for Alzheimer's disease, sponsored by Sinphar Pharmaceutical Co., Ltd; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• STA-1

Snippet

Sponsor: Sinphar Pharmaceutical Co., Ltd | Conditions: Alzheimer Disease | Phase 2 | Status: UNKNOWN